Insider trades
Mahkam Zanganeh, CEO of Summit Therapeutics SMMT, has filed 15 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $51.9M. The latest trade was on 06/12.
Mahkam Zanganeh
Co-CEO
- Company
- Summit Therapeutics SMMT
- First filing
- 23/03/08
- Trades
- 61 trades
- Buys / sales
- 15 / 0
- 12-month net buying
- $51.9M
- Last trade
- 06/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 06/12 | 06/12 | 3,810,000 sh | $13.12 | $49,987,200 | +0.7% | |
| Open-market buy | 06/04 | 06/04 | 100,000 sh | $14.60 | $1,460,000 | +0.4% | |
| Open-market buy | 25/10/21 | 25/10/23 | 26,680 sh | $18.74 | $499,983.2 | +53.4% | |
SMMT | Open-market buy | 25/09/10–25/09/11 | 25/09/11 | 338,394 sh2 trades | $17.69avg. | $5,984,755.92 | +0.1% |
SMMT | Open-market buy | 24/03/26–24/03/27 | 24/03/27 | 110,321 sh4 trades | $3.73avg. | $411,094.12 | No record |
| Open-market buy | 23/12/12 | 23/12/13 | 5,000 sh | $2.07 | $10,350 | +1.0% | |
SMMT | Open-market buyAmendment | 23/03/08 | 23/03/13 | 23,527,044 sh2 trades | $1.05avg. | $24,703,396.2 | No record |
SMMT | Open-market buy | 23/03/08 | 23/03/08 | 23,527,044 sh3 trades | $1.05avg. | $24,703,396.2 | No record |